BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9457825)

  • 21. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
    Mac Manus MP; Rainer Bowie CA; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):365-71. PubMed ID: 9788417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
    Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
    König L; Dreyling M; Dürig J; Engelhard M; Hohloch K; Viardot A; Witzens-Harig M; Kieser M; Klapper W; Pott C; Herfarth K
    Trials; 2019 Aug; 20(1):544. PubMed ID: 31470902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University.
    Murtha AD; Rupnow BA; Hansosn J; Knox SJ; Hoppe R
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):3-15. PubMed ID: 11163492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involved-field irradiation in combination with total-body irradiation (TBI) does not increase short-term toxicity compared to TBI alone in patients with advanced-stage low-grade non-Hodgkin lymphoma.
    Ott M; Schmidberger H; Wörmann B; Albrecht CF; Pradier O; Hess CF
    Strahlenther Onkol; 2002 May; 178(5):245-51. PubMed ID: 12082683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas.
    Ganem G; Lambin P; Socié G; Girinsky T; Bosq J; Pico JL; Solal-Céligny P; Cosset JM
    Hematol Oncol; 1994; 12(1):1-8. PubMed ID: 8194839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
    Ha CS; Tucker SL; Blanco AI; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1207-12. PubMed ID: 10613314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
    Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ
    J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
    Weick JK; Antunez A; Kraus TA; Fabian CJ; Dixon D
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1205-7. PubMed ID: 6347997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
    Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
    Lichtman SM; Petroni G; Schilsky RL; Johnson JL; Perri RT; Niedzwiecki D; Sklar J; Barcos M; Peterson BA
    Leuk Lymphoma; 2001; 42(6):1255-64. PubMed ID: 11911406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Retrospective analysis of a series of 50 patients.
    Fakhrian K; Klemm S; Keller U; Bayer C; Riedl W; Molls M; Geinitz H
    Strahlenther Onkol; 2012 Jun; 188(6):464-70. PubMed ID: 22349634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern.
    Meerwaldt JH; Carde P; Burgers JM; Monconduit M; Thomas J; Somers R; Sizoo W; Glabbeke MV; Duez N; de Wolf-Peeters C
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1167-72. PubMed ID: 1938514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology.
    Tsang RW; Gospodarowicz MK; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):643-51. PubMed ID: 11849785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation.
    Guckenberger M; Alexandrow N; Flentje M
    Radiat Oncol; 2012 Jun; 7():103. PubMed ID: 22726938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
    Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II study.
    Link BK; Martin P; Kaminski MS; Goldsmith SJ; Coleman M; Leonard JP
    J Clin Oncol; 2010 Jun; 28(18):3035-41. PubMed ID: 20458031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.
    Chen CI; Crump M; Tsang R; Stewart AK; Keating A
    Br J Haematol; 2001 Apr; 113(1):202-8. PubMed ID: 11328303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
    Ha CS; Tucker SL; Blanco AI; Wilder RB; McLaughlin P; Cabanillas F; Cox JD
    Cancer; 2001 Sep; 92(5):1074-9. PubMed ID: 11571717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.